The estimated CD4+ T-cell density at the IM was significantly associated with low tumor stage (p < 0.0001), negative nodal stage (p = 0.024) and linked to prolonged overall and progression free survival (≤0.012, Table S2, Table S3, Figure S4). Here, CD4 is linked to neoplasm.